Our findings thus reveal an overlooked tumor‐promoting effect of MSCs in the TME by increasing the expression of NK inhibitory ligands in CTCs via an intercellular cGAS‐STING‐IFNβ‐HLA signaling loop, which helps CTCs evade NK cell surveillance in the blood. Here, IFNB1 is linked to neoplasm.